HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Appendix Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sahani, D. V. Articles by Zhu, A. X. Search for Related Content PubMed PubMed Citation Articles by Sahani, D. V. Articles by Zhu, A. X.

Advanced Hepatocellular Carcinoma: CT Perfusion of Liver and Tumor Tissue—Initial Experience¹

¹ From the Department of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital, 55 Fruit St, White 270, Boston, MA 02114 (D.V.S., N.S.H., P.R.M.); and Cancer Center, COX-2-201, Massachusetts General Hospital, Boston, Mass (A.X.Z.). From the 2005 RSNA Annual Meeting. Received December 12, 2005; revision requested February 7, 2006; revision received May 24; accepted June 8; final version accepted September 15. Address correspondence to D.V.S. (e-mail: dsahani{at}partners.org).

Purpose: To prospectively assess computed tomographic (CT) perfusion for evaluation of tumor vascularity of advanced hepatocellular carcinoma (HCC) and to correlate CT perfusion parameters with tumor grade and serum markers.

Materials and Methods: The study was HIPAA compliant and was approved by the institutional review board. Patients provided informed consent. Thirty patients (22 men, eight women; mean age, 60 years; range, 28–79 years) with unresectable or metastatic HCC were studied. Dynamic first-pass CT perfusion was performed in primary (n = 25) and metastatic (n = 5) HCCs after intravenous injection of contrast medium. Data were analyzed to calculate tissue blood flow, blood volume, mean transit time, and permeability–surface area product. Repeat examination was performed in four patients within 30 hours to test reproducibility of CT perfusion. CT perfusion parameters were compared among tumors of different grades, with presence or absence of portal vein invasion, with presence or absence of cirrhosis, and of various extrahepatic metastases. Parameters were correlated with HCC serum markers. One-way analysis of variance was used to calculate variations in CT perfusion parameters.

Results: Good correlation (r = 0.9, P < .01) was observed between repeat examination results and first CT examination results. There was a significant difference (P .05) in CT perfusion parameters between primary HCC and background liver parenchyma. Well-differentiated HCC showed significantly higher perfusion values (P .05) than other grades. There was no significant difference in tumor perfusion between presence or absence of portal vein invasion or cirrhosis. Lymph node metastasis demonstrated lower values compared with metastases from other extrahepatic sites. There was no significant correlation between CT perfusion parameters and serum markers.

Conclusion: Results suggest that CT perfusion is a feasible and, from the limited data, reproducible technique for quantifying tumor vascularity and angiogenesis in advanced HCC.

Supplemental material: http://radiology.rsnajnls.org/cgi/content/full/243/3/736/DC1

© RSNA, 2007

This article has been cited by other articles:

				A. Sabir, R. Schor-Bardach, C. J. Wilcox, S. Rahmanuddin, M. B. Atkins, J. B. Kruskal, S. Signoretti, V. D. Raptopoulos, and S. N. Goldberg Perfusion MDCT Enables Early Detection of Therapeutic Response to Antiangiogenic Therapy Am. J. Roentgenol., July 1, 2008; 191(1): 133 - 139. [Abstract] [Full Text] [PDF]